XML 35 R23.htm IDEA: XBRL DOCUMENT v3.22.2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($)
$ in Millions
4 Months Ended
Jun. 18, 2022
Jun. 19, 2021
Concentration Risk [Line Items]    
Net sales and other revenue $ 23,310.3 $ 21,269.4
Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 23,310.3 $ 21,269.4
Percentage of total net sales and other revenue 100.00% 100.00%
Non-perishables | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 11,446.0 $ 10,742.7
Percentage of total net sales and other revenue 49.10% 50.50%
Fresh | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 7,881.5 $ 7,412.5
Percentage of total net sales and other revenue 33.80% 34.90%
Pharmacy | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 1,923.5 $ 1,728.6
Percentage of total net sales and other revenue 8.30% 8.10%
Fuel | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 1,654.7 $ 1,049.3
Percentage of total net sales and other revenue 7.10% 4.90%
Other | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 404.6 $ 336.3
Percentage of total net sales and other revenue 1.70% 1.60%